Free Trial

CME Group Inc. Plans Quarterly Dividend of $1.30 (NASDAQ:CME)

CME Group logo with Finance background
Image from MarketBeat Media, LLC.

CME Group Inc. (NASDAQ:CME - Get Free Report) announced a quarterly dividend on Thursday, May 7th. Investors of record on Tuesday, June 9th will be paid a dividend of 1.30 per share by the financial services provider on Thursday, June 25th. This represents a c) annualized dividend and a yield of 1.8%. The ex-dividend date is Tuesday, June 9th.

CME Group has decreased its dividend by an average of 0.0%annually over the last three years. CME Group has a dividend payout ratio of 44.8% indicating that its dividend is sufficiently covered by earnings. Analysts expect CME Group to earn $12.76 per share next year, which means the company should continue to be able to cover its $5.20 annual dividend with an expected future payout ratio of 40.8%.

CME Group Stock Performance

CME stock traded down $1.49 during midday trading on Thursday, reaching $286.85. 2,363,997 shares of the company's stock traded hands, compared to its average volume of 2,291,190. CME Group has a 52-week low of $257.17 and a 52-week high of $329.16. The stock has a market cap of $103.94 billion, a P/E ratio of 24.48, a PEG ratio of 3.47 and a beta of 0.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock's 50-day moving average is $302.15 and its 200 day moving average is $287.14.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same period last year, the firm earned $2.80 earnings per share. The company's quarterly revenue was up 14.5% on a year-over-year basis. As a group, analysts anticipate that CME Group will post 12.26 EPS for the current year.

Analyst Ratings Changes

CME has been the topic of a number of recent research reports. Piper Sandler raised their target price on CME Group from $313.00 to $329.00 and gave the stock an "overweight" rating in a report on Wednesday, April 15th. The Goldman Sachs Group cut their price target on CME Group from $275.00 to $267.00 and set a "sell" rating for the company in a report on Thursday, April 23rd. Keefe, Bruyette & Woods initiated coverage on CME Group in a research report on Wednesday, April 8th. They issued a "market perform" rating and a $305.00 price target for the company. TD Cowen decreased their price objective on CME Group from $340.00 to $323.00 and set a "buy" rating on the stock in a research note on Thursday, April 23rd. Finally, Weiss Ratings raised CME Group from a "buy (b+)" rating to a "buy (a-)" rating in a research report on Monday, March 2nd. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, CME Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $305.29.

Read Our Latest Report on CME

CME Group Company Profile

(Get Free Report)

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

See Also

Dividend History for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines